Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

BACKGROUND: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). METHODS: We randomly assigned inpatients with C...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727327/
https://www.ncbi.nlm.nih.gov/pubmed/33264556
http://dx.doi.org/10.1056/NEJMoa2023184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727327/
https://www.ncbi.nlm.nih.gov/pubmed/33264556
http://dx.doi.org/10.1056/NEJMoa2023184

Ejemplares similares